Press Releases

2014  | 2013  | 2012  | 2011  | 2010  | 2009  | 2008  | 2007  | 2006  | 2005  | 2004  | 2003  | 2002  | 2001  | 2000

All Releases
View Summary ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2014 Financial Results
Apr 17, 2014
PDF 5.7 KB
View Summary ImmunoGen, Inc. Announces First Clinical Findings with Refined Dosing Strategy for IMGN853
Apr 8, 2014
PDF 45.0 KB
View Summary ImmunoGen, Inc. Announces Presentations by Company Scientists at Upcoming AACR Annual Meeting
Mar 17, 2014
PDF 44.4 KB
View Summary ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
Feb 27, 2014
PDF 5.9 KB
View Summary ImmunoGen, Inc. Appoints Ellie Harrison as Chief Human Resources Officer
Feb 20, 2014
PDF 6.0 KB
View Summary ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
Feb 6, 2014
PDF 5.9 KB
View Summary ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
Jan 31, 2014
PDF 6.2 KB
View Summary ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2014 Financial Results and Provides Corporate Update
Jan 31, 2014
PDF 87.2 KB
View Summary ImmunoGen, Inc. Announces Conference Call to Discuss its Second Quarter Fiscal Year 2014 Financial Results
Jan 24, 2014
PDF 5.9 KB
View Summary CytomX Therapeutics and ImmunoGen, Inc. Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets
Jan 9, 2014
PDF 10.9 KB
View Summary ImmunoGen, Inc. Announces Webcast of Presentation at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2014
PDF 5.8 KB
View Summary ImmunoGen, Inc. Appoints David Johnston as Chief Financial Officer
Dec 30, 2013
PDF 5.8 KB
View Summary ImmunoGen, Inc. Announces Activity Reported with SAR3419 Plus Rituxan In Difficult-to-Treat Patient Population
Dec 9, 2013
PDF 8.8 KB
View Summary ImmunoGen, Inc. Announces Favorable Initial Safety and Response Findings for CD38-Targeting Anticancer Compound, SAR650984
Dec 9, 2013
PDF 10.8 KB
View Summary ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming 55th ASH Annual Meeting and Exposition
Dec 3, 2013
PDF 6.4 KB
View Summary ImmunoGen, Inc. Announces Approval of Roche's Kadcyla® in the European Union
Nov 20, 2013
PDF 7.5 KB
View Summary ImmunoGen, Inc. Named One of The Boston Globe's Top Places to Work
Nov 17, 2013
PDF 5.7 KB
View Summary ImmunoGen, Inc. Announces Fifth New License Agreement in 2013
Nov 11, 2013
PDF 5.0 KB
View Summary ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
Nov 8, 2013
PDF 6.2 KB
View Summary ImmunoGen, Inc. Announces Discontinuation of IMGN901 Study in Small-Cell Lung Cancer (SCLC)
Nov 5, 2013
PDF 42.8 KB
Showing 1-20 of 395 Page: 1 2 3 4 5 ... 20  Next 20